Chimerix

Patents

We have established a strong intellectual property (IP) portfolio comprised of numerous U.S. and international patents.  Our IP estate protects our technology and biological insights, our research and development candidates, and the investment the company and its shareholders have made in pioneering and developing its technologies. 

Chimerix is the owner or exclusive licensee of over 20 issued patents covering our PIM (phospholipid intramembrane microfluidization) Conjugate Technology.  Chimerix continues to refine the PIM Conjugate Technology and file new provisional applications.  We also have patents covering composition of matter for each of our PIM Conjugate Technology compounds.

We also have exclusive licenses to 12 US patents covering the Townsend Chemical Library from the University of Michigan.  The Townsend Chemical Library is a unique collection of diverse small molecules encompassing 10,000+ heterocyclic compounds and nucleoside analogues.